Stanford, CANCT07081217Now EnrollingIRB Ready

Healthy Subjects Clinical Trial in Stanford, CA

Access cutting-edge healthy subjects treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.

Sponsored by Lutroo Imaging LLC

Quick Self-Assessment

See if you qualify for this Stanford location

Preparing your pre-screening questions…

Expert Care in Stanford

Access healthy subjects specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related healthy subjects treatment provided free

Apply for This Stanford Location

Check if you qualify for this healthy subjects clinical trial in Stanford, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Stanford

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Stanford site if eligible
  4. 4Begin participation

About This Healthy Subjects Study in Stanford

This is a Phase 1, single-center, open-label study evaluating the safety, biodistribution, and radiation dosimetry of Radiocaine™, an investigational fluorine-18-labeled PET radiotracer designed to bind voltage-gated sodium channels. The study enrolls adult volunteers and aims to inform future clinical development in molecular imaging applications. Radiocaine™ is being developed as a potential diagnostic imaging agent and imaging biomarker for the localization and quantification of sodium channel activity.

Sponsor: Lutroo Imaging LLC

Who Can Participate

Inclusion Criteria

18 years and older
Able to provide written consent
Willing and able to undergo ECG, imaging, blood sampling, and complete self-assessment rating scales at the specified time points
Unremarkable baseline health without report of chronic or acute pain
Willing and able to participate in all imaging procedures and complete the self-assessment rating scales at the specified time points

Exclusion Criteria

Body mass index (BMI) of 32 or greater, weight \>300 lbs
Diagnosis of severe depression/anxiety (PROMIS score \> 95%) or suicidal ideation
History of opioid abuse or opioid use disorder
History of seizures or epilepsy
History of major Axis I or Axis II psychiatric disorder that might, in the opinion of the investigator, make it difficult for the subject to complete all the procedures (e.g. obsessive-compulsive disorder, bipolar disorder, schizophrenia, or schizoaffective disorder)
History of cardiac arrhythmia
History of major orthopedic surgery within the last 12 months
Recent history (previous 6 months) of sodium channel blocker use, including, but not limited to: carbamazepine, lamotrigine, lidocaine, phenytoin, propranolol, or valproate
Any significant systemic illness or medical condition that could lead to difficulty complying with the study protocol
Creatinine clearance (calculated using the Cockcroft-Gault formula or measured) \< 60 mL/min or serum creatinine \>1.5 x ULN
QTcF \>470 msec for females and QTcF \>450 msec for males on screening ECG
MRI-incompatible implants, large tattoos, previous shrapnel injury
Pregnancy or lactating
History of contact sport participation, such as football, hockey, or rugby
Known claustrophobia related to MR or PET-MRI scanners
Recent blood donation/draw of \>1 unit (previous 4 weeks)
History of hypersensitivity to local anesthetics of the amide type
Family or personal history of familial malignant hyperthermia

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Stanford?

Yes, this clinical trial (NCT07081217) has an active research site in Stanford, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Healthy Subjects Treatment Options in Stanford, CA

If you're searching for healthy subjects treatment options in Stanford, CA, this clinical trial (NCT07081217) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced healthy subjects specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all healthy subjects clinical trials near you to find additional studies recruiting in your area.

More Carpal Tunnel Trials in Stanford, CA

See all carpal tunnel clinical trials recruiting in Stanford — not just this study.

Browse Carpal Tunnel Trials in Stanford →

Browse More Trials by Condition

Carpal Tunnel TrialsAll Conditions →

Ready to Join in Stanford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Stanford, CA